Mutation analysis of the p73 gene in nonastrocytic brain tumours

British Journal of Cancer

Volumn 85, Issue 2, 2001, Pages 204-208

  Alonso, M E ^a   Bello, M J ^a   Gonzalez Gomez, P ^a   Lomas, J ^a   Arjona, D ^a   Campos, J M de ^b   Kusak, M E ^b   Sarasa, J L ^c   Isla, A ^a   Rey, J A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

LOH 1p36; Nonastrocytic tumours; p73 gene; Primary brain lymphoma

Indexed keywords

PROTEIN P53; PROTEIN P73;

AMINO ACID SUBSTITUTION; ARTICLE; BRAIN LYMPHOMA; BRAIN METASTASIS; BRAIN TUMOR; CHROMOSOME 1P; CONTROLLED STUDY; EPENDYMOMA; GENE MUTATION; HEMANGIOPERICYTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MEDULLOBLASTOMA; MENINGIOMA; MISSENSE MUTATION; NEURILEMOMA; NEUROFIBROSARCOMA; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEINS;

EID: 17844407158     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1855     Document Type: Article

References (44)

1. Allelic status of chromosome 1 in neoplasms of the nervous system
2. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogeneic events in oligodendroglial tumors
3. High-resolution analysis of chromosome arm 1p alterations in meningioma
4. hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas
5. A device for processing large acrylamide gels
6. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation
7. Additional complexity in p73: Induction by mitogens in limphoid cells and identification of two new splicing variants ε and ζ
8. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53
9. Infrequent somatic mutations of the p73 gene in various human cancers
10. Allelic losses and genetic instabilities of PTEN and p73 in non-Hodgkin lymphomas
11. p53 mutations in human cancers
12. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gone from 1p32 in oligodendroglial tumors
13. p73 at chromosome 1p36 is lost in advanced stage neuroblastoma but its mutation is infrequent
14. p73 is a human p53-related protein that can induce apoptosis
15. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
16. Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation
17. Histological typing of tumors of the nervous system
18. Shared allelic losses on chromosome 1p and 19q suggest a common origin of oligodendrogliom and oligoastrocytoma
19. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningioma
20. Structure, function and regulation of p63 and p73
21. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
22. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
23. Differential expression and allelotyping of the p73 gene in neuroblastoma
24. Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1p-arm deletions
25. Detection of p53 gene mutations in human tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products
26. Search for mutations of the hRAD54 gene in sporadic meningioma with deletion at 1p32
27. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
28. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers
29. p53 mutations in nonastrocytic brain tumors
30. Genetic alterations of p73 are infrequent but may occur in early stage hepatocellular carcinoma
31. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
32. Loss of heterozygosity for dsital markers on 22q in human gliomas
33. Allelic losses on chromosome 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression
34. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
35. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma
36. The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3
37. Mutation analysis of p73 and TP53 in Merkel cell carcinoma
38. 1p36: Every subband a suppressor?
39. Molecular pathways in the formation of gliomas
40. DNA damage enables p73
41. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities
42. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours
43. Alterations of p73 preferentially occur in gastric adeno carcinomas with faveolar epithelial phenotype
44. Mutational analysis of p73 and p53 in human cancer cell lines